511.133.01062 Boehringer Ingelheim Investigational Site

Washington D.C., District of Columbia

0 studies enrolling now · 1 studies all time

What they study most

Sexual Dysfunctions, Psychological

Studies at this site

• A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder — Stopped early